Skip to Content

L006 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint L006 is Purple, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L006

Divalproex sodium delayed-release 250 mg L006

Divalproex Sodium Delayed-Release

Imprint:
L006
Strength:
250 mg
Color:
Purple
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Lupin Pharmaceuticals, Inc
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
68180-0266 Lupin Pharmaceuticals, Inc.
68084-0314 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide